Characterization of SIV-specific CD4+ T-helper proliferative responses in macaques immunized with live-attenuated SIV

Journal of Medical Primatology

Volumn 28, Issue 4-5, 1999, Pages 233-241

  Gauduin, Marie Claire ^a   Glickman, Rhona L ^a   Ahmad, Shabbir ^b   Yilma, Tilahun ^b   Johnson, R Paul ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

AIDS vaccines; CD4+ T helper responses; Simian immunodeficiency virus

Indexed keywords

GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 2; LIVE VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; FLOW CYTOMETRY; HELPER CELL; IMMUNIZATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MACACA; MONKEY DISEASE; SIMIAN IMMUNODEFICIENCY VIRUS;

AIDS VACCINES; ANIMALS; CD4 LYMPHOCYTE COUNT; FLOW CYTOMETRY; IMMUNITY, CELLULAR; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MACACA MULATTA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, HELPER-INDUCER; VACCINES, ATTENUATED;

EID: 0033173955     PISSN: 00472565     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0684.1999.tb00274.x     Document Type: Article

References (32)

1. ADAMS P, OPREMCAK E, OROSZ C: Limiting dilution analysis of human, tetanus-reactive helper T lymphocytes: a rapid method for the enumeration of helper T lymphocytes with specificity for soluble antigens J Immunol Methods 142:231-241, 1991.
2. AHMAD S, LOHMAN B, MARTHAS M, GIAVEDONI L, EL-AMAD Z, HAIGWOOD N, SCANDELLA C, GARDNER M, LUCIW P, YILMA T: Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Res Hum Retroviruses 10:195-204, 1994.
3. ALMOND N, KENT K, CRANAGE M, RUD E, CLARKE B, STOTT EJ: Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345:1342-1344, 1995.
4. CLERICI M, BERZOFSKY J: Cellular immunity and cytokines in HIV infection. AIDS 8:8175-182, 1994.
5. + T cells. Science 270:1811-1815, 1995.
6. CRANAGE M, WHATMORE A, SHARPE S, COOK N, POLYANSKAYA N, LEECH S, SMITH J, RUD E, DENNIS M, HALL G: Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa. Virology 229:143-154, 1997.
7. DANIEL MD, KIRCHHOFF F, CZAJAK SC, SEHGAL PK, DESROSIERS RC: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941, 1992.
8. + T lymphocyte proliferative response in bovine herpesvirus 1 immune cattle. Vet Immunol Immunopathol 42:275-286, 1994.
9. DITTMER U, LUKE W, STAHL-HENNING C, COULIBALY C, PETRY H, BODEMER W, HUNAMANN G, VOSS G: Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques. J Med Primatol 23:298-303, 1994.
10. DITTMER U, NISSLEIN T, BODEMER W, PETRY H, SAUERMANN U, STAHL HC, HUNSMANN G: Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology 212:392-397, 1995.
11. FAZEKAS DE ST. GROTH S: The evaluation of limiting dilution assays. J Immunol Methods 49:R11-R23, 1982.
12. + T lymphocytes from macaques immunized with live attenuated SIV. J Virol 72:6315-6324, 1998.
13. HADIDA F, VIEILLARD V, AUTRAN B, CLARK-LEWIS I, BAGGIOLONI M, DEBRE P: HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3. J Exp Med 188:609-614, 1998.
14. HEENEY J, TEEUWSEN V, VAN GILS M, BOGERS W, DE GIULI MORGHEN C, RADAELLI A, BARNETT S, MOREIN B, AKERBLOM L, WANG Y, LEHNER T, DAVIS D: Chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques. Proc Natl Acad Sci USA 95:10803-10808, 1998.
15. JOHNSON R, LIFSON J, CZAJAK S, COLE K, MANSON K, GLICKMAN R, YANG J, MONTEFIORI D, MONTELARO R, WYAND M, DESROSIERS R: Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relation of degree of protection with level of attenuation. J Virol 73:4952-4961, 1999.
16. JOHNSON RP, GLICKMAN RL, YANG JQ, KAUR A, DION JT, MULLIGAN MJ, DESROSIERS RC: Induction of vigorous cytotoxic T lymphocyte responses by live attenuated simian immunodeficiency virus. J Virol 71:7711-7718, 1997.
17. KALAMS S, WALKER B: The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med 188:2199-2204, 1998.
18. KAWAI T, WONG J, MACLEAN J, COSIMI AB, WEE S: Characterization of a monoclonal antibody (6G12) recognizing the cynomolgus monkey CD3 antigen. Transplant Proc 26:1845-1846, 1994.
19. KESTLER H, KODAMA T, RINGLER D, MARTHAS M, PEDERSEN N, LACKNER A, REGIER D, SEDGAL P, DANIEL M, KING N, DESROSIERS R: Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248:1109-1112, 1990.
20. KESTLER HW, RINGLER DJ, MORI K, PANICALI DL, SEHGAL PD, DANIEL MD, DESROSIERS RC: Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662, 1991.
21. LOHMAN BL, MCCHESNEY MB, MILLER CJ, MCGOWAN E, JOYE SM, VANROMPAY KKA, REAY E, ANTIPA L, PEDERSEN NC, MARTHAS ML: A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J Virol 68:7021-7029, 1994.
22. OHKAWA S, WILSON L, LAROSA G, JAVAHERIAN K, MARTIN L, MURPHEY-CORB M: Immune responses induced by prototype vaccines for AIDS in rhesus monkeys. AIDS Res Hum Retroviruses 10:27-38, 1994.
23. PAL R, GARZINO-DEMO A, MARKHAM PD, BURNS J, BROWN M, GALLO RC, DEVICO AL: Inhibition of HIV-1 infection by the beta-chemokine MDC. Science 278:695-698, 1997.
24. PRUSSIN C, METCALFE D: Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 188:117-128, 1995.
25. + T cells during initiation of infection. J Exp Med 179:447-456, 1994.
26. + T cell responses associated with control of viremia. Science 278:1447-1450, 1997.
27. STAHL-HENNIG C, VOSS G, DITTMER U, COULIBALY C, PETRY H, MAKOSCHEY B, CRANAGE MP, AUBERTIN AM, LUKE W, HUNSMANN G: Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virus. AIDS 7:787-795, 1993.
28. VOSS G, DITTMER U, COULIBALY C, MAKOSCHEY B, PETRY H, LUKE W, HUNSMANN G: Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130. Virology 74:1757-1763, 1993.
29. VOSS G, DITTMER U, NICK S, STAHL-HENNING C, COULIBALY C, PETRY H, LUKE W, HUNSMANN G: Induction of T cell proliferation in rhesus macaques immunized with Tween-ether-treated SIVmac and loss of proliferative activity after virus infection. In: Racz P, Letvin NL, Gluckman JC (eds). Animal Models of HIV and Other Retroviral Infections. Karger: Basel 86-94, 1993.
30. VOSS G, NICK S, STAHL-HENNIG C, COULIBALY C, PETRY H, LUKE W, HUNSMANN G: Potential significance of the cellular immune response against the macaque strain of simian immunodeficiency virus (SIVmac) in immunized and infected rhesus macaques. J Gen Virol 73:2273-2281, 1992.
31. WYAND MS, MANSON KH, GARCIA-MOLL M, MONTEFIORI D, DESROSIERS RC: Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol 70:3724-3733, 1996.
32. XU X-N, SCREATON GR, GOTCH FM, DONG T, TAN R, ALMOND N, WALKER B, STEBBINGS R, KENT K, NAGATA S, STOTT JE, MCMICHAEL AJ: Evasion of CTL responses by nef-dependent induction of fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J Exp Med 186:7-16, 1997.